Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Medicare Premiums and Aduhelm: The Political Headache Continues
CMS HAS YET TO PUZZLE OUT HOW TO LOWER MEDICARE PREMIUMS EVEN AFTER BIOGEN CUT ADUHELM’S PRICE AND MEDICARE OPTED NOT TO COVER THE PRODUCT OUTSIDE OF TRIALS. • Source: Getty
More from Medicare
More from Government Payers